We are live on
!
Find out more
TG
TCW Group Portfolio holdings
AUM
$13.3B
1-Year Est. Return
34.44%
This Fund
S&P 500
This Quarter
Est. Return
+4.95%
1 Year Est. Return
+34.44%
3 Year Est. Return
+125.95%
5 Year Est. Return
+105.75%
10 Year Est. Return
+505.62%
AUM
$12.3B
AUM Growth
+$34.7M
(+0.28%)
Cap. Flow
-$380M
Cap. Flow
% of AUM
-3.08%
Top 10 Holdings %
Top 10 Hldgs %
22.6%
Holding
381
New
24
Increased
129
Reduced
151
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$84.3M |
| 2 |
United Parcel Service
UPS
|
+$51.1M |
| 3 |
Amneal Pharmaceuticals
AMRX
|
+$45.3M |
| 4 |
nVent Electric
NVT
|
+$36.5M |
| 5 |
TechnipFMC
FTI
|
+$35.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cardinal Health
CAH
|
+$89.7M |
| 2 |
Fastenal
FAST
|
+$71.9M |
| 3 |
IPXL
Impax Laboratories, Inc.
IPXL
|
+$45.6M |
| 4 |
Starbucks
SBUX
|
+$35.9M |
| 5 |
Microsoft
MSFT
|
+$35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.01% |
| 2 | Financials | 20% |
| 3 | Healthcare | 11.46% |
| 4 | Consumer Discretionary | 11.28% |
| 5 | Communication Services | 8.76% |
Similar funds
MGIA
EPFB
RCMU
WA
AA
TWIM
PFPG
AB
TCW Group's Q2 2018 Portfolio in Review
As of Q2 2018, TCW Group held 381 positions worth $12.3B, up 0.28% from $12.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
TCW Group withdrew a net $380M in Q2 2018, closing 46 positions and reducing 151 holdings. Its most notable exit was Impax Laboratories, Inc., an estimated $45.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, TCW Group opened a new position in Amneal Pharmaceuticals worth $42.4M.
- TCW Group's largest Q2 2018 buy was Amneal Pharmaceuticals: 2,583,162 shares worth $42.4M.
- TCW Group added most to NVIDIA in Q2 2018, an estimated $84.3M increase.
- TCW Group's biggest Q2 2018 reduction was Cardinal Health, cutting an estimated $89.7M.
- TCW Group fully exited Impax Laboratories, Inc. in Q2 2018, selling an estimated $45.6M.
- TCW Group's ten largest holdings make up 23% of its $12.3B portfolio in Q2 2018.
- TCW Group opened 24 new positions and closed 46 in Q2 2018.
- TCW Group's portfolio value rose 0.28% quarter-over-quarter to $12.3B.
Based on TCW Group's 13F filing for Q2 2018, filed 2 Aug 2018.